Clinical Research on Retinal Neovascularization of Diabetic Retinopathy

Tianjin Medical University

Status: Terminated

Conditions: The Mechanism of Retinal Neovascularization of Diabetic; Retinopathy.

Treatments: Genetic: genetic analyzer

Study type: Interventional

Funder types: Other

Identifiers

NCT01229540

08ZCGYSF01700 (Other Identifier)

Details and patient eligibility

About

Retinal neovascularization of diabetic retinopathy might be associated with genetic risk factors and environmental risk factors.

Sex: All

Ages: 45 to 74 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• T2DM was diagnosed according to the World Health Organization Expert Consultation Report 1999 and consisted of one of the following: fasting blood glucose (FBG) ≥7.0 mmol/L (≥126 mg/dL), blood glucose ≥11.1 mmol/L (≥200 mg/dL) 2 hours after an oral glucose tolerance test (OGTT); or a random blood glucose ≥11.1 mmol/L (≥200 mg/dL).
• DR was clinically graded in accordance with the International Clinical Diabetic Retinopathy guidelines based on fundus fluorescence angiography.
• All participants with PDR underwent a comprehensive dilated fundus examination to detect DR by indirect ophthalmoscopy and were diagnosed by fundus fluorescence angiography.

Exclusion criteria

• Patients were excluded if they had acute complications of diabetes mellitus, type 1 diabetes mellitus, other types of diabetes, serious cardiovascular, hepatic, nephritic or other complications, other serious primary diseases or mental illness.

Trial design

0 participants in 1 patient group

Lifestyle counseling

No Intervention group

Treatment:

Genetic: genetic analyzer